Derek S. Chiu
YOU?
Author Swipe
View article: Clinical outcomes of combination therapy for hepatocellular carcinoma in a predominantly hispanic South Texas population
Clinical outcomes of combination therapy for hepatocellular carcinoma in a predominantly hispanic South Texas population Open
Background/Aim Currently, studies looking at hepatocellular carcinoma treatments with combination immunotherapy and locoregional therapies are limited in scope. Our study aimed to further clarify the impact of combination therapy using imm…
View article: Co-existent endometrial and ovarian carcinoma: molecular and pathological features define low risk entity
Co-existent endometrial and ovarian carcinoma: molecular and pathological features define low risk entity Open
FIGO IA3 criteria identify a subset of co-existent endometrial and ovarian carcinomas with excellent outcomes. However, incorporating molecular features into the definition enables greater prognostic discernment and supports the inclusion …
View article: Prognostic values of molecular subtypes and SWI/SNF protein expression in de‐differentiated/undifferentiated endometrial carcinoma
Prognostic values of molecular subtypes and SWI/SNF protein expression in de‐differentiated/undifferentiated endometrial carcinoma Open
Aims Classification and risk stratification of endometrial carcinoma (EC) has transitioned from histopathological features to molecular classification, e.g. the ProMisE classifier, identifying four prognostic subtypes: POLE mutant ( POLE m…
View article: Serum CA125 levels in the context of ProMisE molecular classification provides pre-operative prognostic information that can direct endometrial cancer management
Serum CA125 levels in the context of ProMisE molecular classification provides pre-operative prognostic information that can direct endometrial cancer management Open
CA125 levels are associated with molecular subtype, stage>I disease, and SEOC/CAM. CA125 remains a useful clinical tool in the triage of EC in the era of molecular classification.
View article: Supplementary Tables S1-S5 from The prognostic effect of immune cell infiltration depends on molecular subtype in Endometrioid Ovarian Carcinomas
Supplementary Tables S1-S5 from The prognostic effect of immune cell infiltration depends on molecular subtype in Endometrioid Ovarian Carcinomas Open
Supplementary Tables S1-S5
View article: Supplementary Tables S1-S5 from The prognostic effect of immune cell infiltration depends on molecular subtype in Endometrioid Ovarian Carcinomas
Supplementary Tables S1-S5 from The prognostic effect of immune cell infiltration depends on molecular subtype in Endometrioid Ovarian Carcinomas Open
Supplementary Tables S1-S5
View article: Data from The prognostic effect of immune cell infiltration depends on molecular subtype in Endometrioid Ovarian Carcinomas
Data from The prognostic effect of immune cell infiltration depends on molecular subtype in Endometrioid Ovarian Carcinomas Open
Purpose: Endometrioid ovarian carcinoma (ENOC) is the second most-common type of ovarian carcinoma, comprising 10-20% of cases. Recently, the study of ENOC has benefitted from comparisons to endometrial carcinomas (EC) including defining E…
View article: Supplementary Figures S1-S4 from The prognostic effect of immune cell infiltration depends on molecular subtype in Endometrioid Ovarian Carcinomas
Supplementary Figures S1-S4 from The prognostic effect of immune cell infiltration depends on molecular subtype in Endometrioid Ovarian Carcinomas Open
Supplementary Figures S1-S4
View article: Supplementary Figures S1-S4 from The prognostic effect of immune cell infiltration depends on molecular subtype in Endometrioid Ovarian Carcinomas
Supplementary Figures S1-S4 from The prognostic effect of immune cell infiltration depends on molecular subtype in Endometrioid Ovarian Carcinomas Open
Supplementary Figures S1-S4
View article: Quantifying Intratumoral Biomarker Heterogeneity in Tubo-ovarian High-grade Serous Carcinoma to Optimize Clinical Translation
Quantifying Intratumoral Biomarker Heterogeneity in Tubo-ovarian High-grade Serous Carcinoma to Optimize Clinical Translation Open
Intratumoral heterogeneity (ITH) is spatial, phenotypic, or molecular differences within the same tumor that have important implications for accurate tumor classification and assessment of predictive biomarkers. The Canadian Ovarian Experi…
View article: Person-Generated Health Data in Women’s Health: Scoping Review
Person-Generated Health Data in Women’s Health: Scoping Review Open
Background The increased pervasiveness of digital health technology is producing large amounts of person-generated health data (PGHD). These data can empower people to monitor their health to promote prevention and management of disease. W…
View article: Ensemble clustering: A practical tutorial
Ensemble clustering: A practical tutorial Open
Cluster analysis is an explorative analytical method, serving as a critical tool in psychology, psychiatry and related fields to map heterogeneous data into meaningful subgroups. Despite their extensive historical use, traditional clusteri…
View article: Person-Generated Health Data in Women’s Health: Scoping Review (Preprint)
Person-Generated Health Data in Women’s Health: Scoping Review (Preprint) Open
BACKGROUND The increased pervasiveness of digital health technology is producing large amounts of person-generated health data (PGHD). These data can empower people to monitor their health to promote prevention and management of disease. …
View article: Supplementary Figures S1-S4 from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas
Supplementary Figures S1-S4 from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas Open
Supplementary Figures S1-S4
View article: Supplementary Tables S1-S5 from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas
Supplementary Tables S1-S5 from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas Open
Supplementary Tables S1-S5
View article: Data from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas
Data from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas Open
Purpose:Endometrioid ovarian carcinoma (ENOC) is the second most-common type of ovarian carcinoma, comprising 10%–20% of cases. Recently, the study of ENOC has benefitted from comparisons to endometrial carcinomas including defining ENOC w…
View article: Supplementary Figures S1-S4 from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas
Supplementary Figures S1-S4 from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas Open
Supplementary Figures S1-S4
View article: Supplementary Tables S1-S5 from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas
Supplementary Tables S1-S5 from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas Open
Supplementary Tables S1-S5
View article: Data from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas
Data from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas Open
Purpose:Endometrioid ovarian carcinoma (ENOC) is the second most-common type of ovarian carcinoma, comprising 10%–20% of cases. Recently, the study of ENOC has benefitted from comparisons to endometrial carcinomas including defining ENOC w…
View article: Supplementary Figures S1-S4 from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas
Supplementary Figures S1-S4 from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas Open
Supplementary Figures S1-S4
View article: Supplementary Tables S1-S5 from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas
Supplementary Tables S1-S5 from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas Open
Supplementary Tables S1-S5
View article: Supplementary Tables S1-S5 from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas
Supplementary Tables S1-S5 from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas Open
Supplementary Tables S1-S5
View article: Data from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas
Data from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas Open
Purpose:Endometrioid ovarian carcinoma (ENOC) is the second most-common type of ovarian carcinoma, comprising 10%–20% of cases. Recently, the study of ENOC has benefitted from comparisons to endometrial carcinomas including defining ENOC w…
View article: Supplementary Figures S1-S4 from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas
Supplementary Figures S1-S4 from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas Open
Supplementary Figures S1-S4
View article: The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas
The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas Open
Purpose: Endometrioid ovarian carcinoma (ENOC) is the second most-common type of ovarian carcinoma, comprising 10%–20% of cases. Recently, the study of ENOC has benefitted from comparisons to endometrial carcinomas including defining ENOC …